Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr;106(4):315-320.
doi: 10.1136/archdischild-2020-319778. Epub 2020 Nov 11.

Clinical management of sickle cell liver disease in children and young adults

Affiliations
Review

Clinical management of sickle cell liver disease in children and young adults

Eirini Kyrana et al. Arch Dis Child. 2021 Apr.

Abstract

Liver involvement in sickle cell disease (SCD) is often referred to as sickle cell hepatopathy (SCH) and is a complication of SCD which may be associated with significant mortality. This review is based on a round-table workshop between paediatric and adult hepatologists and haematologists and review of the literature. The discussion was prompted by the lack of substantial data and guidance in managing these sometimes very challenging cases. This review provides a structured approach for the diagnosis and management of SCH in children and young adults. The term SCH describes any hepatobiliary dysfunction in the context of SCD. Diagnosis and management of biliary complications, acute hepatic crisis, acute hepatic sequestration and other manifestations of SCH are discussed, as well as the role of liver transplantation and haemopoietic stem cell transplantation in the management of SCH.

Keywords: adolescent health; gastroenterology; jaundice.

PubMed Disclaimer

Conflict of interest statement

Competing interests: EK, FL, EF, MDa, NHe, SH, MS, FM, VB, AS, AV, MV, BI, ED, NHa, TG, JH, MDe, MS and AD have nothing to disclose. DR is on advisory boards of Novartis and DSMB of AstraZeneca outside the submitted work. GG reports personal fees from Alexion Pharmaceuticals outside the submitted work. SC reports personal fees from Novartis outside the submitted work. VB reports personal fees from Bluebirdbio and from Addmedica, outside the submitted work.

Figures

Figure 1
Figure 1. Pathophysiology of sickle cell hepatopathy
The polymerization of deoxygenated HbS is the origin of all the complications of SCD. It increases the rigidity of the red cell with consequent damage to the vascular endothelium and vaso-occlusion, resulting in a cascade of pathological processes, including infarction, haemolysis, inflammation, hypercoagulability and oxidative stress. HbS: haemoglobin S Permission has been obtained from the illustrator Dr Vassiliki Tzomaka to include the above illustration in the figure of this article.
Figure 2
Figure 2. Sickling in end arteries of bile ducts
The diagram on the left illustrates the sickling in the end arteries perfusing the bile ducts. The picture on the right is an MRCP of a child with sickle cholangiopathy showing intrahepatic cholangiopathy with dilatations and strictures but no dominant stricture. MRCP: magnetic resonance cholangiopancreatography
Figure 3
Figure 3. Biopsy changes in sickle cell hepatopathy
Liver biopsy from an 11-year-old showing sinusoidal dilatation (long arrow) and porto-portal bridging fibrosis (short arrows). Sickle cells are visible within the sinusoids in this biopsy from a 12-year-old (B, main image). In acute hepatic sequestration, large numbers of sickled cells can be seen within congested sinusoids (B, lower inset). Iron overload can be seen within cells of the reticuloendothelial system (upper inset) and hepatocytes (long arrow). A liver biopsy from a 17-year-old demonstrating features of autoimmune liver disease in the form of a porto-lobular hepatitis with plasma cell rich interface activity (C, main image). The same child demonstrated cholangiopathic features in the form of concentric periductal fibrosis (C, lower inset) and periductal lymphoplasmacytic inflammation around portal areas (C, upper inset). Cholangiopathic features in the form of duct loss attributed to ischaemic damage demonstrated in panel D. Duct destruction was a prominent feature of this biopsy from a 7-year-old with sickle cell disease and autoimmune liver disease. The upper inset demonstrates a destructive cholangitis affecting interlobular calibre bile ducts (D, upper inset, H&E x200 magnification) and the lower inset demonstrates plasma cell rich inflammation surrounding septal calibre bile ducts (D, lower inset).

References

    1. Hamideh D, Alvarez O. Sickle cell disease related mortality in the United States (1999-2009) Pediatr Blood Cancer. 2013;60(9):1482–6. - PubMed
    1. Shah R, Taborda C, Chawla S. Acute and chronic hepatobiliary manifestations of sickle cell disease: A review. World J Gastrointest Pathophysiol. 2017;8(3):108–16. - PMC - PubMed
    1. Allali S, de Montalembert M, Brousse V, et al. Hepatobiliary Complications in Children with Sickle Cell Disease: A Retrospective Review of Medical Records from 616 Patients. J Clin Med. 2019;8(9) - PMC - PubMed
    1. Alkindi SY, Pathare A, Al Zadjali S, et al. Serum Total Bilirubin, not Cholelithiasis, is Influenced by UGT1A1 Polymorphism, Alpha Thalassemia and beta(s) Haplotype: First Report on Comparison between Arab-Indian and African beta(s) Genes. Mediterr J Hematol Infect Dis. 2015;7(1):e2015060. - PMC - PubMed
    1. Walker TM, Hambleton IR, Serjeant GR. Gallstones in sickle cell disease: observations from The Jamaican Cohort study. J Pediatr. 2000;136(1):80–5. - PubMed

Publication types

MeSH terms

LinkOut - more resources